Is hypertension associated with an accelerated aging of the brain?

Hypertension

Volumn 63, Issue 5, 2014, Pages 894-903

  Tzourio, Christophe ^a,b   Laurent, Stéphane ^c   Debette, Stéphanie ^b,d  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

^c PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGING; ANTIHYPERTENSIVE THERAPY; ARTERIAL PRESSURE; ARTERIAL STIFFNESS; ARTERIOLOSCLEROSIS; AUTOREGULATION; BLOOD PRESSURE; BRAIN; BRAIN AGING; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN DISEASE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN MICROCIRCULATION; CARDIOVASCULAR RISK; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; EXECUTIVE FUNCTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MEMORY; MICROVASCULAR ISCHEMIA; MIDDLE CEREBRAL ARTERY; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERFUSION; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; PULSE WAVE ENCEPHALOPATHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; VASCULAR BRAIN INJURY; VASCULAR RESISTANCE; WHITE MATTER LESION;

AGING, PREMATURE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAIN; CEREBROVASCULAR TRAUMA; COGNITION DISORDERS; DEMENTIA; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MASS SCREENING; RISK FACTORS;

EID: 84902288922     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.00147     Document Type: Review

References (108)

1. Wilkie F, Eisdorfer C. Intelligence and blood pressure in the aged. Science. 1971; 172: 959-962.
2. Elias MF, Goodell AL, Dore GA Hypertension and cognitive functioning: a perspective in historical context. Hypertension. 2012; 60: 260-268.
3. World Health Organization and Alzheimer's Disease International. Dementia. A Public Health Priority. 2012. http://www.who.int/mental-health/ publications/dementia-report-2012/en/. Accessed May 3, 2012.
4. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007; 3: 186-191. (Pubitemid 46825511)
5. Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: how to move forward? Neurology. 2009; 72: 368-374.
6. O'Donnell M.J., Xavier D, Liu L., et al.; INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010; 376: 112-123.
7. Zhu L, Fratiglioni L, Guo Z., Basun H, Corder EH, Winblad B, Viitanen M. Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study. Stroke. 2000; 31: 53-60. (Pubitemid 30035752)
8. Ivan CS, Seshadri S, Beiser A., Au R, Kase CS, Kelly-Hayes M, Wolf PA. Dementia after stroke: the Framingham Study. Stroke. 2004; 35: 1264-1268. (Pubitemid 38697439)
9. Snowdon DA, Greiner LH, Mortimer J.A., Riley KP, Greiner PA, Markesbery WR Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997; 277: 813-817. (Pubitemid 27111317)
10. Law MR, Morris JK, Wald NJ Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemio-logical studies. BMJ. 2009; 338:b1665.
11. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet. 2001; 358: 1033-1041.
12. Tzourio C, Anderson C, Chapman N., Woodward M, Neal B, MacMahon S., Chalmers J; PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003; 163: 1069-1075. (Pubitemid 36548935)
13. Elias MF, Dore GA, Davey A, Robbins M.A., Elias PK From blood pressure to physical disability: the role of cognition. Hypertension. 2010; 55: 1360-1365.
14. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol. 1993; 138: 353-364. (Pubitemid 23289288)
15. Skoog I, Lernfelt B, Landahl S., Palmertz B, Andreasson LA, Nilsson L, Persson G., Odén A, Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996; 347: 1141-1145. (Pubitemid 126512042)
16. Launer LJ, Ross GW, Petrovitch H, Masaki K., Foley D, White LR, Havlik RJ Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000; 21: 49-55. (Pubitemid 30224785)
17. Kivipelto M, Helkala EL, Laakso M.P., Hänninen T, Hallikainen M., Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001; 322: 1447-1451. (Pubitemid 32575406)
18. Debette S, Seshadri S, Beiser A., Au R, Himali JJ, Palumbo C, Wolf P.A., DeCarli C. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011; 77: 461-468.
19. Carmelli D, Swan GE, Reed T, Miller B., Wolf PA, Jarvik GP, Schellenberg GD Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology. 1998; 50: 1580-1585. (Pubitemid 28283221)
20. Plassman BL, Williams JW Jr, Burke Jr, Holsinger T, Benjamin S. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med. 2010; 153: 182-193.
21. Whitmer RA, Sidney S, Selby J., Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005; 64: 277-281.
22. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011; 10: 819-828.
23. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005; 4: 487-499. (Pubitemid 40982459)
24. Kennelly SP, Lawlor BA, Kenny RA Blood pressure and dementia - a comprehensive review. Ther Adv Neurol Disord. 2009; 2: 241-260.
25. Debette S, Seshadri S. Vascular risk factors and dementia revisited. J Neurol Neurosurg Psychiatry. 2009; 80: 1183-1184.
26. Dumurgier J, Elbaz A, Dufouil C., Tavernier B, Tzourio C. Hypertension and lower walking speed in the elderly: the Three-City study. J Hypertens. 2010; 28: 1506-1514.
27. Gorelick PB, Scuteri A, Black S.E., et al.; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42: 2672-2713.
28. In't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging. 2001; 22: 407-412. (Pubitemid 32510912)
29. Morris MC, Scherr PA, Hebert L.E., Glynn RJ, Bennett DA, Evans DA Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol. 2001; 58: 1640-1646. (Pubitemid 32963229)
30. Lindsay J, Laurin D, Verreault R., Hébert R, Helliwell B., Hill GB, McDowell I. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol. 2002; 156: 445-453. (Pubitemid 34976983)
31. Guo Z, Fratiglioni L, Zhu L., Fastbom J, Winblad B, Viitanen M. Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol. 1999; 56: 991-996. (Pubitemid 29374817)
32. Qiu C, von Strauss E, Fastbom J, Winblad B., Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol. 2003; 60: 223-228. (Pubitemid 36193966)
33. Khachaturian AS, Zandi PP, Lyketsos C.G., Hayden KM, Skoog I, Norton MC, Tschanz J.T., Mayer LS, Welsh-Bohmer KA, Breitner JC. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 2006; 63: 686-692.
34. Haag MD, Hofman A, Koudstaal P.J., Breteler MM, Stricker BH Duration of antihypertensive drug use and risk of dementia: a prospective cohort study. Neurology. 2009; 72: 1727-1734.
35. Peila R, White LR, Masaki K, Petrovitch H., Launer LJ Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke. 2006; 37: 1165-1170. (Pubitemid 43731856)
36. SHEP Cooperative Research Group. Prevention of stroke by antihyperten-sive drug treatment in older persons with isolated systolic hypertension: final results of the systolic hypertension in the elderly program (SHEP). JAMA. 1991; 265: 3255-3264.
37. Lithell H, Hansson L, Skoog I., Elmfeldt D, Hofman A, Olofsson B., Trenkwalder P, Zanchetti A; SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003; 21: 875-886. (Pubitemid 36677151)
38. Peters R, Beckett N, Forette F., Tuomilehto J, Clarke R, Ritchie C., Waldman A, Walton I, Poulter R, Ma S, Comsa M, Burch L, Fletcher A, Bulpitt C. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebocontrolled trial. Lancet Neurol. 2008; 7: 683-689.
39. Prince MJ, Bird AS, Blizard R.A., Mann AH Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ. 1996; 312: 801-805. (Pubitemid 26099297)
40. Forette F, Seux ML, Staessen J.A., et al Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998; 352: 1347-1351. (Pubitemid 28510916)
41. Forette F, Seux ML, Staessen J.A., et al.; Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002; 162: 2046-2052. (Pubitemid 35168212)
42. Longstreth WT Jr. Brain vascular disease overt and covert. Stroke. 2005; 36: 2062-2063. (Pubitemid 41429213)
43. Debette S, Markus HS The clinical importance of white matter hyper-intensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010; 341:c3666.
44. Vermeer SE, Longstreth WT Jr, Koudstaal PJ Silent brain infarcts: a systematic review. Lancet Neurol. 2007; 6: 611-619. (Pubitemid 46921055)
45. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain micro-bleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain. 2007; 130(Pt 8): 1988-2003. (Pubitemid 47236609)
46. Zhu YC, Dufouil C, Mazoyer B., Soumaré A, Ricolfi F, Tzourio C, Chabriat H. Frequency and location of dilated Virchow-Robin spaces in elderly people: a population-based 3D MR imaging study. Am J Neuroradiol. 2011; 32: 709-713.
47. Wen W, Sachdev PS, Li J.J., Chen X., Anstey KJ White matter hyperinten-sities in the forties: their prevalence and topography in an epidemiological sample aged 44-48. Hum Brain Mapp. 2009; 30: 1155-1167.
48. Pantoni L, Garcia JH Pathogenesis of leukoaraiosis: a review. Stroke. 1997; 28: 652-659. (Pubitemid 27118393)
49. de Reuck J. The cortico-subcortical arterial angio-architecture in the human brain. Acta Neurol Belg. 1972; 72: 323-329.
50. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013; 12: 483-497.
51. Guo X, Pantoni L, Simoni M., Bengtsson C, Björkelund C, Lissner L., Gustafson D, Skoog I. Blood pressure components and changes in relation to white matter lesions: a 32-year prospective population study. Hypertension. 2009; 54: 57-62.
52. Verhaaren BF, Vernooij MW, de Boer R, Hofman A, Niessen W.J., van der Lugt A, Ikram MA. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension. 2013; 61: 1354-1359.
53. Dufouil C, de Kersaint-Gilly A, Besançon V, Levy C, Auffray E, Brunnereau L, Alpérovitch A, Tzourio C. Longitudinal study of blood pressure and white matter hyperintensities: the E VA MRI Cohort. Neurology. 2001; 56: 921-926. (Pubitemid 32290809)
54. de Leeuw F.E., de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J, Breteler MM. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain. 2002; 125(Pt 4): 765-772. (Pubitemid 34279772)
55. van Dijk E.J., Breteler MM, Schmidt R, Berger K., Nilsson LG, Oudkerk M, Pajak A, Sans S., de Ridder M, Dufouil C, Fuhrer R, Giampaoli S, Launer LJ, Hofman A; CASCADE Consortium. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension. 2004; 44: 625-630. (Pubitemid 39435230)
56. Gottesman RF, Coresh J, Catellier D.J., Sharrett AR, Rose KM, Coker LH, Shibata D.K., Knopman DS, Jack CR, Mosley TH Jr. Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2010; 41: 3-8.
57. Hajjar I, Quach L, Yang F., Chaves PH, Newman AB, Mukamal K, Longstreth W Jr, Inzitari M, Lipsitz LA. Hypertension, white matter hyperintensities, and concurrent impairments in mobility, cognition, and mood: the Cardiovascular Health Study. Circulation. 2011; 123: 858-865.
58. Godin O, Tzourio C, Maillard P., Mazoyer B, Dufouil C. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation. 2011; 123: 266-273.
59. Maillard P, Seshadri S, Beiser A., Himali JJ, Au R, Fletcher E, Carmichael O., Wolf PA, DeCarli C. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol. 2012; 11: 1039-1047.
60. Shah NS, Vidal JS, Masaki K, Petrovitch H., Ross GW, Tilley C, DeMattos RB, Tracy R.P., White LR, Launer LJ. Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study. Hypertension. 2012; 59: 780-786.
61. Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir M.K., Kjartansson Ó, Garcia M, Aspelund T, Harris TB, Gudnason V, Launer LJ. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility-Reykjavik study. Brain. 2011; 134(Pt 11): 3398-3407.
62. Henskens LH, Kroon AA, van Oostenbrugge RJ, Gronenschild EH, Fuss-Lejeune MM, Hofman PA, Lodder J, de Leeuw PW. Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients. Hypertension. 2008; 52: 1120-1126.
63. Brisset M, Boutouyrie P, Pico F., Zhu Y, Zureik M, Schilling S., Dufouil C, Mazoyer B, Laurent S, Tzourio C, Debette S. Large-vessel correlates of cerebral small-vessel disease. Neurology. 2013; 80: 662-669.
64. O'Rourke M.F., Safar ME Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005; 46: 200-204. (Pubitemid 40946514)
65. Laurent S, Briet M, Boutouyrie P. Large and small artery cross-talk and recent morbidity-mortality trials in hypertension. Hypertension. 2009; 54: 388-392.
66. de Leeuw F.E., Richard F, de Groot JC, van Duijn CM, Hofman A, van Gijn J, Breteler MM. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke. 2004; 35: 1057-1060. (Pubitemid 38543516)
67. Schmidt H, Zeginigg M, Wiltgen M., Freudenberger P, Petrovic K, Cavalieri M., Gider P, Enzinger C, Fornage M, Debette S, Rotter JI, Ikram MA, Launer LJ, Schmidt R; CHARGE Consortium Neurology Working Group. Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease. Brain. 2011; 134(Pt 11): 3384-3397.
68. Inzitari D, Pracucci G, Poggesi A., et al.; LADIS Study Group. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ. 2009; 339:b2477.
69. Debette S, Beiser A, DeCarli C., Au R, Himali JJ, Kelly-Hayes M, Romero J.R., Kase CS, Wolf PA, Seshadri S. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke. 2010; 41: 600-606.
70. Rost NS, Rahman RM, Biffi A, Smith E.E., Kanakis A., Fitzpatrick K, Lima F, Worrall B.B., Meschia JF, Brown RD Jr, Brott TG, Sorensen AG, Greenberg SM, Furie KL, Rosand J. White matter hyperintensity volume is increased in small vessel stroke subtypes. Neurology. 2010; 75: 1670-1677.
71. Folsom AR, Yatsuya H, Mosley TH Jr, Psaty BM, Longstreth WT Jr. Risk of intraparenchymal hemorrhage with magnetic resonance imaging-defined leukoaraiosis and brain infarcts. Ann Neurol. 2012; 71: 552-559.
72. Kuller LH, Lopez OL, Newman A, Beauchamp N.J., Burke G., Dulberg C, Fitzpatrick A, Fried L., Haan MN. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology. 2003; 22: 13-22. (Pubitemid 36131969)
73. Longstreth WT J.r., Arnold AM, Beauchamp NJ Jr, Manolio TA, Lefkowitz D, Jungreis C, Hirsch C.H., O'Leary DH, Furberg CD. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke. 2005; 36: 56-61. (Pubitemid 40054175)
74. van Dijk E.J., Prins ND, Vrooman H.A., Hofman A., Koudstaal PJ, Breteler MM Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke. 2008; 39: 2712-2719.
75. Duering M, Zieren N, Hervé D, Jouvent E, Reyes S, Peters N, Pachai C, Opherk C, Chabriat H, Dichgans M. Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL. Brain. 2011; 134(Pt 8): 2366-2375.
76. Debette S, Bombois S, Bruandet A., Delbeuck X, Lepoittevin S, Delmaire C., Leys D, Pasquier F. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment. Stroke. 2007; 38: 2924-2930. (Pubitemid 350041561)
77. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Koudstaal P.J., Oudkerk M., Hofman A, Breteler MM. Cerebral white matter lesions and the risk of dementia. Arch Neurol. 2004; 61: 1531-1534. (Pubitemid 39350263)
78. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal P.J., Hofman A., Breteler MM. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain. 2005; 128(Pt 9): 2034-2041. (Pubitemid 41253271)
79. Nordahl CW, Ranganath C, Yonelinas A.P., Decarli C., Fletcher E, Jagust WJ White matter changes compromise prefrontal cortex function in healthy elderly individuals. J Cogn Neurosci. 2006; 18: 418-429.
80. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004; 5: 347-360. (Pubitemid 38568496)
81. Arvanitakis Z, Leurgans SE, Wang Z, Wilson R.S., Bennett DA, Schneider JA Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol. 2011; 69: 320-327.
82. Viswanathan A, Greenberg SM Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011; 70: 871-880.
83. Soumaré A, Elbaz A, Zhu Y, Maillard P, Crivello F, Tavernier B, Dufouil C, Mazoyer B, Tzourio C. White matter lesions volume and motor performances in the elderly. Ann Neurol. 2009; 65: 706-715.
84. Baezner H, Blahak C, Poggesi A., et al.; LADIS Study Group. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology. 2008; 70: 935-942. (Pubitemid 351430742)
85. Godin O, Dufouil C, Maillard P., Delcroix N, Mazoyer B, Crivello F., Alpérovitch A, Tzourio C. White matter lesions as a predictor of depression in the elderly: the 3C-Dijon study. Biol Psychiatry. 2008; 63: 663-669. (Pubitemid 351329279)
86. Teodorczuk A, O'Brien JT, Firbank MJ, Pantoni L, Poggesi A., Erkinjuntti T, Wallin A, Wahlund L.O., Gouw A., Waldemar G, Schmidt R, Ferro JM, Chabriat H, Bäzner H, Inzitari D; LADIS Group. White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry. 2007; 191: 212-217. (Pubitemid 47435050)
87. Dufouil C, Chalmers J, Coskun O., Besançon V, Bousser M.G., Guillon P., MacMahon S, Mazoyer B, Neal B, Woodward M, Tzourio-Mazoyer N, Tzourio C; PROGRESS MRI Substudy Investigators. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation. 2005; 112: 1644-1650. (Pubitemid 41324527)
88. Weber R, Weimar C, Blatchford J., Hermansson K, Wanke I, Möller-Hartmann C, Gizewski ER, Forsting M, Demchuk AM, Sacco RL, Saver JL, Warach S, Diener HC, Diehl A; PRoFESS Imaging Substudy Group. Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy. Stroke. 2012; 43: 2336-2342.
89. Zhu YC, Tzourio C, Soumaré A, Mazoyer B, Dufouil C, Chabriat H. Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study. Stroke. 2010; 41: 2483-2490.
90. Weller RO, Subash M, Preston S.D., Mazanti I., Carare RO Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol. 2008; 18: 253-266. (Pubitemid 351430402)
91. Zhu YC, Dufouil C, Soumaré A, Mazoyer B, Chabriat H, Tzourio C. High degree of dilated Virchow-Robin spaces on MRI is associated with increased risk of dementia. J Alzheimers Dis. 2010; 22: 663-672.
92. Poels MM, Ikram MA, van der Lugt A, Hofman A, Niessen WJ, Krestin GP, Breteler MM, Vernooij MW. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology. 2012; 78: 326-333.
93. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal P.J., Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003; 348: 1215-1222. (Pubitemid 36359297)
94. Nilsson PM, Boutouyrie P, Laurent S. Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension. 2009; 54: 3-10.
95. Laurent S, Cockcroft J, van Bortel L, Boutouyrie P, Giannattasio C., Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006; 27: 2588-2605. (Pubitemid 44627304)
96. Webb AJ, Simoni M, Mazzucco S., Kuker W, Schulz U, Rothwell PM Increased cerebral arterial pulsatility in patients with leukoaraiosis: arterial stiffness enhances transmission of aortic pulsatility. Stroke. 2012; 43: 2631-2636.
97. Marshall RS, Lazar RM Pumps, aqueducts, and drought management: vascular physiology in vascular cognitive impairment. Stroke. 2011; 42: 221-226.
98. Joutel A, Monet-Leprêtre M, Gosele C, Baron-Menguy C, Hammes A, Schmidt S, Lemaire-Carrette B, Domenga V, Schedl A, Lacombe P, Hubner N. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J Clin Invest. 2010; 120: 433-445.
99. Baumbach GL. Effects of increased pulse pressure on cerebral arterioles. Hypertension. 1996; 27: 159-167. (Pubitemid 26045912)
100. Christensen KL. Reducing pulse pressure in hypertension may normalize small artery structure. Hypertension. 1991; 18: 722-727.
101. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Sever P.S., Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010; 375: 895-905.
102. Alperovitch A, Blachier M, Soumare A., Ritchie K, Dartigues JF, Richard-Harston S, Tzourio C. Blood pressure variability and risk of dementia in an elderly cohort, the three-city study [published online ahead of print August 14, 2013]. Alzheimer's Dement. doi: 10.1016/j.jalz.2013.05.1777. http://www.alzheimersanddementia.com/article/S1552-5260(13)02474-6/abstract. Accessed February 14, 2014.
103. Schillaci G, Bilo G, Pucci G., Laurent S, Macquin-Mavier I, Boutouyrie P, Battista F., Settimi L, Desamericq G, Dolbeau G, Faini A, Salvi P, Mannarino E, Parati G. Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension. 2012; 60: 369-377.
104. Bateman GA, Levi CR, Schofeld P, Wang Y., Lovett EC The venous manifestations of pulse wave encephalopathy: windkessel dysfunction in normal aging and senile dementia. Neuroradiology. 2008; 50: 491-497. (Pubitemid 351763582)
105. Henry Feugeas M.C., de Marco G, Peretti II, Godon-Hardy S, Fredy D., Claeys ES. Age-related cerebral white matter changes and pulse-wave encephalopathy: observations with three-dimensional MRI. Magn Reson Imaging. 2005; 23: 929-937. (Pubitemid 41681673)
106. Scheltens P, Barkhof F, Leys D., Wolters EC, Ravid R, Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology. 1995; 45: 883-888.
107. White WB, Wolfson L, Wakefield D.B., Hall CB, Campbell P, Moscufo N, Schmidt J., Kaplan RF, Pearlson G, Guttmann CR. Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people. Circulation. 2011; 124: 2312-2319.
108. Goldstein LB, Bushnell CD, Adams R.J., et al.; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research, Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42: 517-584.